Eye Dynamics, Inc. ( OTCBB: EYDY, Trade), a leading provider of health and safety products, today announced it has retained Richard Studdard, former head of Los Angeles Police Department's Drug Recognition Expert Unit, to expand the company's law enforcement market program. According to a company spokesperson, the company took this action in response to the positive reaction it has received as a direct result of its marketing efforts for the Video HGN Goggle System.

"Eye Dynamics is pleased to be able to work with Dick Studdard. As an expert in his field, and with over 34 years of law enforcement experience, he is the perfect person to expand this market." Said Ron Waldorf, Chairman & CEO of Eye Dynamics.

The company believes that in the form of its Video HGN Goggle System, it is able to provide the law enforcement community with a powerful training tool for personnel involved in administering the Standardized Field Sobriety Test (SFST) as well as those involved in the nation's Drug Recognition Expert Program. The SFST is used in every state for roadside determination of driving under the influence. The DRE Program exists by state law in almost 40 states. Both were developed by the federal government.

Studdard will be responsible for increasing awareness of and demand for the company's HGN System amongst uniformed agencies as well as nonprofit associations whose mission is to support the reduction of motor vehicle crashes resulting from drunk/drugged driving.. Currently, Video HGN Systems are being used by the California Highway Patrol and other agencies as well as specialized research institutions.

Studdard, a retired Sergeant of the Los Angeles Police Department (LAPD), received the Distinguished Service Medal and Meritorious Unit Medal in the course of his career. Prior to his retirement from the LAPD, he supervised the Driving Under the Influence (DUI) Enforcement units. In addition, he served as officer-in-charge of the department's Drug Recognition Expert (DRE) Unit and was the DRE Training Coordinator for the State of California. Studdard also served as a Special Consultant on the Drug Evaluation and Classification Program, Technical Advisory Panel, of the International Association of Chiefs of Police and was a lead investigator in various research projects on alcohol and drug signs from Johns Hopkins University, the National Highway Traffic Safety Administration and the National Institute on Drug Abuse.

About Eye Dynamics, Inc.

Eye Dynamics is in the business of producing and marketing patented proprietary products and other services for the institutional, medical and government markets. The company is a leader in the Video ENG medical product market, having invented the Video ENG system and brought it to market in 1994. SafetyScope, the company's latest product, is designed for the 'fitness-for-duty' screening of workers. SafetyScope is simple to use, takes only 90 seconds and does not require any bodily fluids like urine-based drug testing. It automates the manual methods of evaluating eye responses of an individual to detect neurological signs of impairment used by law enforcement throughout the United States. To find out more about Eye Dynamics, Inc. visit: www.eyedynamics.com.

As previously announced, Eye Dynamics signed a Letter of Intent to acquire OrthoNetx (Superior, CO www.orthonetx.com), a leading provider of medical devices for osteoplastic surgery and 'human data consent' technology for medical device and clinical applications. The acquisition will be completed as a stock transaction. Due diligence has been successfully completed. The acquisition is subject to certain customary conditions including certain regulatory approvals.

About OrthoNetx, Inc.

OrthoNetx, Inc. designs, develops, manufactures and markets patented, FDA-approved medical devices and systems for osteoplastic surgery and distraction osteogenesis- the practice of generating, forming and molding bone. Physician customers include plastic surgeons, oral and maxillofacial surgeons, otolaryngologists, and orthopedic surgeons who correct deformities and deficiencies of the skeleton caused by errors of birth, trauma, infections and tumors. Osteoplastic surgery is applicable to all areas of the skeleton, including the skull and face, jaws, long bones of the upper and lower extremities, hands, wrists, feet, ankles, and the spine. The privately-held company is headquartered in Superior, CO. For more information visit: www.orthonetx.com.

Safe Harbor for Forward Looking Statements

This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.